Michael Mason - 06 Feb 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
EVP, CFO & Treasurer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Michael Mason
Issuer symbol
KPTI
Transactions as of
06 Feb 2023
Net transactions value
-$14,079
Form type
4
Filing time
08 Feb 2023, 15:11:19 UTC
Previous filing
01 Sep 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $14,079 -4,141 -2.5% $3.40 164,368 06 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.